Tang G, Lai J, Pervaiz S
Haematologica. 2023; 109(1):33-43.
PMID: 37584295
PMC: 10772529.
DOI: 10.3324/haematol.2023.283730.
Shi K, Lu H, Zhang Z, Fu Y, Wu J, Zhou S
Cell Death Differ. 2022; 30(1):195-207.
PMID: 36171331
PMC: 9883455.
DOI: 10.1038/s41418-022-01064-2.
Kawiak A, Kostecka A
Cancers (Basel). 2022; 14(2).
PMID: 35053443
PMC: 8773933.
DOI: 10.3390/cancers14020279.
Singh P, Roukounakis A, Weber A, Das K, Sohm B, Villunger A
Cell Death Differ. 2019; 27(2):434-450.
PMID: 31189926
PMC: 7206095.
DOI: 10.1038/s41418-019-0365-y.
Singh P, Weber A, Hacker G
Cell Cycle. 2018; 17(9):1037-1047.
PMID: 30019621
PMC: 6110606.
DOI: 10.1080/15384101.2018.1464851.
Phosphorylation alters Bim-mediated Mcl-1 stabilization and priming.
Conage-Pough J, Boise L
FEBS J. 2018; 285(14):2626-2640.
PMID: 29775995
PMC: 6215700.
DOI: 10.1111/febs.14505.
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes.
Rahman M, MacNeil S, Jenkins D, Shrestha G, Wyatt S, McQuerry J
Genome Med. 2017; 9(1):40.
PMID: 28446242
PMC: 5406893.
DOI: 10.1186/s13073-017-0429-x.
Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia.
Pan R, Ruvolo V, Wei J, Konopleva M, Reed J, Pellecchia M
Blood. 2015; 126(3):363-72.
PMID: 26045609
PMC: 4504949.
DOI: 10.1182/blood-2014-10-604975.
Trichonomas vaginalis metalloproteinase induces apoptosis of SiHa cells through disrupting the Mcl-1/Bim and Bcl-xL/Bim complexes.
Quan J, Kang B, Cha G, Zhou W, Koh Y, Yang J
PLoS One. 2014; 9(10):e110659.
PMID: 25343522
PMC: 4208800.
DOI: 10.1371/journal.pone.0110659.
Mcl-1 ubiquitination: unique regulation of an essential survival protein.
Mojsa B, Lassot I, Desagher S
Cells. 2014; 3(2):418-37.
PMID: 24814761
PMC: 4092850.
DOI: 10.3390/cells3020418.
A novel Mcl1 variant inhibits apoptosis via increased Bim sequestration.
Hagenbuchner J, Kiechl-Kohlendorfer U, Obexer P, Ausserlechner M
Oncotarget. 2013; 4(8):1241-52.
PMID: 23872733
PMC: 3787154.
DOI: 10.18632/oncotarget.1147.
Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiforme.
Cartron P, Loussouarn D, Campone M, Martin S, Vallette F
Cell Death Dis. 2012; 3:e421.
PMID: 23152057
PMC: 3542591.
DOI: 10.1038/cddis.2012.150.
Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells.
Merino D, Khaw S, Glaser S, Anderson D, Belmont L, Wong C
Blood. 2012; 119(24):5807-16.
PMID: 22538851
PMC: 3382939.
DOI: 10.1182/blood-2011-12-400929.
Discovery of marinopyrrole A (maritoclax) as a selective Mcl-1 antagonist that overcomes ABT-737 resistance by binding to and targeting Mcl-1 for proteasomal degradation.
Doi K, Li R, Sung S, Wu H, Liu Y, Manieri W
J Biol Chem. 2012; 287(13):10224-10235.
PMID: 22311987
PMC: 3323047.
DOI: 10.1074/jbc.M111.334532.
Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo.
Clybouw C, Merino D, Nebl T, Masson F, Robati M, OReilly L
Cell Death Differ. 2012; 19(6):1060-8.
PMID: 22240894
PMC: 3354058.
DOI: 10.1038/cdd.2011.198.
Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia.
Yamamoto-Sugitani M, Kuroda J, Ashihara E, Nagoshi H, Kobayashi T, Matsumoto Y
Proc Natl Acad Sci U S A. 2011; 108(42):17468-73.
PMID: 21987825
PMC: 3198366.
DOI: 10.1073/pnas.1111138108.
BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma.
Bodet L, Menoret E, Descamps G, Pellat-Deceunynck C, Bataille R, Le Gouill S
Br J Cancer. 2010; 103(12):1808-14.
PMID: 21063407
PMC: 3008608.
DOI: 10.1038/sj.bjc.6605981.